Jennison Associates LLC Verona Pharma PLC Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Jennison Associates LLC holds 1,128,032 shares of VRNA stock, worth $39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,128,032
Previous 1,593,833
29.23%
Holding current value
$39 Million
Previous $25.6 Million
36.39%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
142Shares Held
66.7MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$264 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$193 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$138 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$123 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$115 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.11B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...